Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1

Status

Recruiting 381Active not recruiting 189Not yet recruiting 94Completed 91Terminated 24Enrolling by invitation 8Suspended 7Withdrawn 3Available 2

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 17Lymphoid 14Other hematologic neoplasm 10Thoracic 9Gastrointestinal 9Breast 8Tumor-Agnostic 5CNS 5Plasma cell 4Dermatologic 4Other solid neoplasm 3Head & Neck 3Gynecologic 3Sarcoma 2Myeloid 2Classical hematology 1

Conditions

Uterine Cervical Neoplasms 2Ovarian Neoplasms 2Uterine Cervical Dysplasia 1Endometrial Neoplasms 1Atypical Squamous Cells of the Cervix 1

Interventions

bemarituzumab 1Restraint, Physical 1Human Papillomavirus DNA Tests 1Colposcopy 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Gynecologic × 90 days × Clear all
NCT07146919 2026-04-23

ANGELICA

Centre Leon Berard

Phase 1/2 Withdrawn
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT07060365 2026-04-03

A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian Cancer

AstraZeneca

Phase 1/2 Withdrawn
Gynecologic

Ovarian Neoplasms

NCT07211204 2026-03-03

Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

Timser SAPI de CV

Phase NA Withdrawn
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡